BRIEF published on 06/26/2026 at 18:05, 1 month 11 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Transparency Notification Shareholding Belgium Atlas Special Opportunities Oxurion
PRESS RELEASE published on 06/26/2026 at 18:00, 1 month 11 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV receives transparency notification regarding shares ownership from Atlas Special Opportunities II, LLC, crossing under the 3% threshold Transparency Notification Euronext Brussels Oxurion NV Shares Ownership Atlas Special Opportunities II LLC
BRIEF published on 06/24/2026 at 18:05, 1 month 13 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Securities Transparency Notification Oxurion Belgian Legislation Atlas Special Opportunities II
PRESS RELEASE published on 06/24/2026 at 18:00, 1 month 13 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV has received a transparency notification regarding changes in shareholding. The company is focused on technology-enabled clinical research and software platform Clinical Research Transparency Notification Shareholding Software Platform Oxurion NV
BRIEF published on 06/19/2026 at 15:50, 1 month 18 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Transparency Notification Shareholding Technology Platform Atlas Special Opportunities Oxurion
PRESS RELEASE published on 06/19/2026 at 15:45, 1 month 18 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC indicating a change in share ownership percentage Transparency Notification Euronext Brussels Share Ownership Oxurion NV Atlas Special Opportunities II LLC
BRIEF published on 06/15/2026 at 19:35, 1 month 22 days ago Oxurion: Exagis adopted by Pierre Fabre Biopharmaceutical Clinical Data Oxurion Exaggerate Pierre Fabre
BRIEF published on 06/15/2026 at 19:35, 1 month 22 days ago Oxurion's Exagis Platform Gains Major Market Validation with Pierre Fabre Laboratories Data Management Pharmaceutical Oxurion Pierre Fabre Exagis Platform
PRESS RELEASE published on 06/15/2026 at 19:30, 1 month 22 days ago Major market validation: Pierre Fabre Laboratories uses Oxurion's Exagis Platform Oxurion NV announces Pierre Fabre Laboratories utilizing Exagis clinical data management platform by Axiodis CRO, enhancing efficiency and compliance. Exagis adapts to various study configurations Oxurion NV Clinical Data Management Axiodis CRO Exagis Pierre Fabre Laboratories
BRIEF published on 06/10/2026 at 18:05, 1 month 27 days ago Oxurion receives a transparency notification from Atlas Special Opportunities II LLC Shares Transparency Euronext Brussels Oxurion Atlas Special Opportunities II LLC
Published on 08/07/2026 at 23:15, 16 hours 17 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 16 hours 32 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 17 hours 2 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 17 hours 17 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/07/2026 at 23:21, 16 hours 11 minutes ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 20 hours 2 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 20 hours 17 minutes ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 21 hours 22 minutes ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 17:45, 21 hours 47 minutes ago Schroder ETFs ICAV: Publication of the Audited Annual Report for Switzerland
Published on 08/07/2026 at 18:54, 20 hours 38 minutes ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 20 hours 52 minutes ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 17:49, 21 hours 43 minutes ago Crédit Agricole CIB announced the publication of the Amendment of its 2025 Universal Registration Document
Published on 08/07/2026 at 08:30, 1 day 7 hours ago Disclosure of shares outstanding and voting rights - 07.08.2026
